DIALYSIS · CCN 492704

DaVita Rutherford Crossing Dialysis

WINCHESTER, VA 22603

DialysisProfitDaVita
$4.0M
TOTAL REVENUE
33.7%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.0M
Total costs
$2.7M
Operating income (rev − costs)
$1.4M
Operating margin
33.7%
Total charges
$4.1M
Total treatments
8,859
Dialysis stations
13

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.854—
Fistula Rate
DFC_FISTULA_RATE
64.455—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.4127—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
183.962—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1855—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
21221—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
21.559—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
28.369—
Standardized ED Visits Ratio
DFC_SEDR
0.6833—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
22.229—